Credence Research’s latest report “Short Bowel Syndrome Market: Global Industry Analysis and Operational Strategies” discusses the deal-making activity during the past five years and in-depth analysis of the key deals involving more than 40 public and privately held CROs. The operational strategies adopted by key players in recent years have been listed. A heatmap analysis of the key companies was done based on their firm utilization and capital management.
The report firstly introduced the Short Bowel Syndrome basics: definitions, classifications, applications, and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost structures and so on. Then it analyzed the world's main region market states, including the product price, profit, capacity, production, capacity utilization, supply, trade and industry growth rate etc. In the end, the report introduced new project SWOT analysis, investment feasibility analysis, and investment return analysis.
[Browse full report: “Short Bowel Syndrome Market Size”]
Market Insights
Short bowel syndrome is a group of complex diseases that occurs due to malfunction of a portion of small and/or large intestine. The individuals with short bowel syndrome exhibit poor absorption of nutrients such as water, fats, carbohydrates, vitamins, minerals and other vital elements which leads to malnutrition, weight loss. However, in some cases, short bowel syndrome can lead to severe, disabling and life-threatening complications.
There is no particular cure to this disorder however surgical removal (resection) of half or more of the small intestine is effective. Short bowel syndrome can lead to Crohn’s disease, injury or trauma to the small intestine. Such complications are making a significant contribution to the growth of the short bowel syndrome market.
On the basis of drug the market is segmented into GLP-2, glutamine, growth hormone and others. GLP-2 currently holds the largest market in terms of drug in the short bowel syndrome market as it is marketed in U.S. and Europe under the brand name Gattex and Revestive in Europe and other international market.
The drugs currently holds the orphan drug status, and the exclusivity of the drugs in the treatment of the short bowel syndrome would further draw huge revenue during the forecast period.
[For a bigger picture try FREE sample of this report now!]
Companies mentioned in the report are (Leading Players)
The short bowel syndrome market comprises large number of pharmaceutical giants operating in the market. Shire holds the largest market share in the short bowel syndrome market. The companies include Merck KGaA, and Emmaus Life Sciences, Inc, Nutrinia Ltd, GlyPharma Therapeutics, OxThera, Ardelyx, Inc, and others.
Report Focus:
The ‘Short Bowel Syndrome - Global Trends, Estimates, and Forecasts, 2017-2025’ reviews the latest trends in this industry with a perceptive to identify the near-future growth prospects. The Short Bowel Syndrome industry is a fragmented market with multiple participants, opens up numerous investment opportunities. An in-depth analysis across the geographic regions provides strategic business intelligence for the industry investments. The Short Bowel Syndrome report study offers profitable investment strategies for R&D organizations, manufacturing units, distributors, Contract Research Organizations (CROs) and many more in preferred locations.
Table of Content:
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Short Bowel Syndrome Market Portraiture
2.2 Short Bowel Syndrome Market, by Drug Type, 2016 (US$ Mn)
2.3 Short Bowel Syndrome Market, by Geography, 2016 (Value %)
Chapter 3 Global Short Bowel Syndrome Market Analysis
3.1 Global Short Bowel Syndrome Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Analysis: Global Short Bowel Syndrome Market, 2016 (Value %)
The report primarily focuses on:
• Latest Short Bowel Syndrome Market Trends
• Region-wise Demand Factor
• Key Growth Areas
• Short Bowel Syndrome Market Sizes
• Key Competitors Edge
• Investment Strategies
Scope
The scope of the Short Bowel Syndrome report includes:
-Overview of key reasons behind outsourcing, outsourcing service models
-Examples of operational strategies
-Global deals analysis by type and value
-Major acquisitions and partnerships
-Regional analysis of North America, Europe, Asia-Pacific and Emerging markets
-Company benchmarking based on heat map analysis
-Vendor positioning
-SWOT analysis and profiles of key players
Reasons to Buy
The Short Bowel Syndrome market report will enhance your decision-making capability by allowing you to:
-Identify the top players in the CRO market, financial revenues and key services offered
-Analyze the key geographies that are lucrative markets for deal-making, market-entry and market expansion strategies
-Analyze the trends in acquisitions, licensing and other types of deals and explore potential investment opportunities
-Understand the operational strategies of key players
[For a bigger picture try FREE sample of this report now!]
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhanShort Bowel Syndromes to their execution and understand their most imperative objectives. Over almost a century, we've manufactured a firm extraordinarily prepared to this task.
Our Blogs:
BrilAd
Mobilecomputingtoday
Contact Us:
Credence Research Inc.
105 N 1st ST #429
SAN JOSE
CA 95103
United States
Toll Free (US/CANADA): +1-800-361-8290
Web: https://www.credenceresearch.com
Follow Us: Twitter
LinkedIn @ https://us.linkedin.com/company/credenceresearch